Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T16:26:40.892Z.
Calculation as of: 2026-10-06T16:26:40.892Z.
Quote observation: 2026-10-06T16:24:48.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 869772d5b15fe2f366f7470de3318cdd420f1d22994776f46b79eb6f67ec6a89
EARNINGS YIELD
N/A
Eupraxia Pharmaceuticals Inc.
Market Cap
$266.50M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$266.05M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$267.48M
Earnings Yield
N/A
TTM Avg
7.35%
3Y Avg
8.08%
5Y Avg
6.30%
Market Cap
$267.03M
Earnings Yield
N/A
TTM Avg
6.60%
3Y Avg
6.60%
5Y Avg
6.49%
Market Cap
$263.05M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$261.24M
Earnings Yield
N/A
TTM Avg
24.17%
3Y Avg
24.17%
5Y Avg
24.17%
Market Cap
$258.23M
Earnings Yield
N/A
TTM Avg
1.20%
3Y Avg
4.13%
5Y Avg
3.97%
Market Cap
$274.62M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Eupraxia Pharmaceuticals Inc. (EPRX) | $266.50M | N/A | N/A | N/A | N/A |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $266.05M | N/A | N/A | N/A | N/A |
| OraSure Technologies, Inc. (OSUR)vs › | $267.48M | N/A | 7.35% | 8.08% | 6.30% |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $267.03M | N/A | 6.60% | 6.60% | 6.49% |
| Lexeo Therapeutics, Inc. Common Stock (LXEO)vs › | $263.05M | N/A | N/A | N/A | N/A |
| Palisade Bio, Inc. (PALI)vs › | $261.24M | N/A | 24.17% | 24.17% | 24.17% |
| Scribe Therapeutics Inc. (SCTX)vs › | $273.40M | N/A | N/A | N/A | N/A |
| Anika Therapeutics, Inc. (ANIK)vs › | $258.23M | N/A | 1.20% | 4.13% | 3.97% |
| Rocket Pharmaceuticals, Inc. (RCKT)vs › | $274.62M | N/A | N/A | N/A | N/A |
| AC Immune S.A. (ACIU)vs › | $256.72M | N/A | 8.07% | 8.07% | 7.35% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
